DHGWA
ARKG icon

Dixon Hughes Goodman Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5K Sell
100
-205
-67% -$9.77K ﹤0.01% 587
2021
Q4 		$19K Buy
+305
New +$21.1K 0.01% 382

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's ARKG Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors reduced its ARK Genomic Revolution ETF (ARKG) stake by 67% in Q1 2022, selling an estimated $9.77K and leaving 100 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Dixon Hughes Goodman Wealth Advisors first reported a position in ARKG in Q4 2021 and has held it in 2 quarters since. The position peaked at $19K in Q4 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 100 shares of ARK Genomic Revolution ETF worth $5K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors sold 205 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $9.77K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #587 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 2 quarters since.
  • Dixon Hughes Goodman Wealth Advisors's ARK Genomic Revolution ETF position peaked at $19K in Q4 2021.
  • 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.